A61K 31/31
Containing nitrogen
Official title: containing nitrogen
A61K31/31 (Containing nitrogen) appears on 21 US grants and 24 published applications in this corpus.
Search patents in A61K- Granted patents
- 21
- Published applications
- 24
- Assignees
- 21
- Inventors
- 67
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 3 |
| 2004 | 2 | 3 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 3 |
| 2014 | 3 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Use of salidroside derivative in external preparation for skin whitening24 Dec 2024US 12,171,856 B2Shanghai Cheermore Biological Technology Co., Ltd.
- Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors4 Oct 2022US 11,458,135 B2Suven Life Sciences Limited
- Treatment of circadian rhythm disorders17 Aug 2021US 11,090,285 B2Vanda Pharmaceuticals Inc.
- Treatment of circadian rhythm disorders15 Aug 2017US 9,730,910 B2Vanda Pharmaceuticals Inc.
- Complex-forming compounds26 Jan 2016US 9,243,031 B2Stratoxer(S) Kft.
- Treatment of circadian rhythm disorders24 Oct 2024US 2024/0350451 A1Vanda Pharmaceuticals Inc.
- Senolytic compounds and compositions19 Oct 2023US 2023/0330058 A1Nuchido Limited
- Exosomes-based therapy for liver fibrosis and other diseases with fibrosis19 Jan 2023US 2023/0013636 A1Board of Regents, The University of Texas System
- Use of salidroside derivative in external preparation for skin whitening12 May 2022US 2022/0142895 A1Shanghai Cheermore Biological Technology Co., Ltd.
- Treatment of circadian rhythm disorders6 May 2021US 2021/0128517 A1Vanda Pharmaceuticals Inc.
Most cited
By later US patents
- Pharmaceutical combinations for treating obesity and food craving102US 6,207,699 B12001
- Enzyme-orthokeratology57US 5,270,051 A1993
- Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor36US 5,260,059 AThe State of Oregon Acting by and through the State Board of Higher Education on Behalf of Oregon Health Sciences University · 1993
- Enzyme-orthokeratology32US 5,626,865 AAdvanced Corneal Systems, Inc. · 1997
- Enzyme-orthokeratology31US 5,788,957 AAdvanced Corneal Systems, Inc. · 1998